Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2025)

Historic Change in Inventory for ARS Pharmaceuticals (SPRY) over the last 2 years, with Q3 2025 value amounting to -$963000.0.

  • ARS Pharmaceuticals' Change in Inventory fell 62622.95% to -$963000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 975300.55%. This contributed to the annual value of $5.9 million for FY2024, which is N/A changed from last year.
  • Per ARS Pharmaceuticals' latest filing, its Change in Inventory stood at -$963000.0 for Q3 2025, which was down 62622.95% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, ARS Pharmaceuticals' Change in Inventory peaked at $8.4 million during Q1 2025, and registered a low of -$963000.0 during Q3 2025.